For Scientific Institutions, Racial Reconciliation Requires Reparations
By C. Brandon Ogbunu,
Scientific American
| 06. 12. 2020
Antiracism in science must be about much more than challenging the bigoted graybeards of our past such as Ronald A. Fisher.
Ronald Fisher as a steward at the First International Eugenics Conference, 1912 (via wikipedia)
Amidst protests and conversations on racism following several instances of police violence, scientific institutions are reevaluating their approach to dealing with anti-Black racism—extant, historical or symbolic. For example, on Wednesday, June 10, a large segment of the scientific community (and the staffs of prominent journals) participated in a strike, where the goal was to reflect on how Black people—students, trainees, staff, and faculty—are treated, and how we can make the scientific paradigm more inclusive.
This includes several ongoing policy discussions surrounding diversity and inclusion, and very specific exchanges about how we remember and celebrate historical figures. For example, the Society for the Study of Evolution (SSE) is one of many influential scientific societies embroiled in a debate over renaming a prestigious award that currently commemorates Ronald A. Fisher (the R.A. Fisher Prize). Fisher was a pioneer of modern population genetics and one of the most influential scientists of the last century. His influence is as great in genetics as it is statistics, the latter...
Related Articles
By Emma McDonald Kennedy
| 10.29.2026
At the beginning of Nathan Fielder and Lance Oppenheim’s blockbuster documentary You Can See Everything, Billy Evans (partner of Theranos founder and convicted fraudster Elizabeth Holmes), says that they decided to do the film for one purpose: “radical transparency.” As they work on “Theranos 2.0,” Evans and Holmes want to show the public that she has been misunderstood –– painted as a liar and a fraud in the public imagination (and the courts) despite, as she claims in the...
By Jonquilyn Hill, Vox | 10.18.2026
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...